InvestorsHub Logo
Followers 6
Posts 1087
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Friday, 03/12/2021 9:31:48 AM

Friday, March 12, 2021 9:31:48 AM

Post# of 17454
BOSTON, March 12, 2021 – The Institute for Clinical and Economic Review (ICER) today released an Evidence Report assessing the comparative clinical effectiveness and value of belimumab (Benlysta®, GlaxoSmithKline) and voclosporin (Lupkynis™, Aurinia) for the treatment of lupus nephritis (LN).

https://icer.org/news-insights/press-releases/icer-publishes-evidence-report-on-therapies-for-lupus-nephritis/

https://icer.org/assessment/lupus-nephritis-2021/#related

https://icer.org/assessment/lupus-nephritis-2021/#timeline

https://icer.org/assessment/lupus-nephritis-2021/#overview
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AUPH News